Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy-Reference-Cited by-同舟云学术

Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy

Published:2021-11 Issue: Volume:911 Page:174516
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Chatterjee Subhajit^ORCID,Sinha Saptarshi^ORCID,Kundu Chanakya Nath^ORCID

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Pharmacology

Reference88 articles.

1. The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma;Athanassiadou;Folia Histochem. Cytobiol.,2011

2. Targeted molecular therapeutics for bladder cancer—a new option beyond the mixed fortunes of immune checkpoint inhibitors?;Bednova;Int. J. Mol. Sci.,2020

3. NECTIN4 (PVRL4) as putative therapeutic target for a specific subtype of high grade serous ovarian cancer—an integrative multi-omics approach;Bekos;Cancers,2019

4. Regression of Burkitt's lymphoma in association with measles infection. Regression of Burkitt's lymphoma in association with measles infection;Bluming;Lancet,1971

5. Nectin-1 binds and signals through the fibroblast growth factor receptor;Bojesen;J. Biol. Chem.,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer;Cancers;2024-09-04

2. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09

3. Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer;JCO Precision Oncology;2024-08

4. Effects of PEGylation on Imaging Contrast of ⁶⁸Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4;Molecular Pharmaceutics;2024-07-29

5. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28